Description
ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-12-30+$841,106= $841,106
- Mod P000012025-04-23+$3,059= $844,165
- Mod P000022025-11-07+$844,165= $1,688,329
- Mod P000032026-05-06+$0= $1,688,329
- Mod P000042026-07-09+$0= $1,688,329
- Mod P000052026-08-19+$105,222= $1,793,552
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-12-30 | +$841,106 | $841,106 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2025-04-23 | +$3,059 | $844,165 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
| Mod P00002· EXERCISE AN OPTION | 2025-11-07 | +$844,165 | $1,688,329 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
| Mod P00003· FUNDING ONLY ACTION | 2026-05-06 | +$0 | $1,688,329 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2026-07-09 | +$0 | $1,688,329 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
| Mod P00005· FUNDING ONLY ACTION | 2026-08-19 | +$105,222 | $1,793,552 | ABBOTT ALINITY CI ANALYZER COST-PER-REPORTABLE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6630 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726F0220 | ABBOTT LABORATORIES INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $204,195 | FY2026 |
| 36C24726N0197 | WERFEN USA LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $87,244 | FY2026 |
| 36C24725F0005 | ABBOTT LABORATORIES INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $591,104 | FY2025 |
| 36C24724P1116 | MILTENYI BIOTEC, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $31,000 | FY2024 |
| 36C24724P1154 | SCIREQ SCIENTIFIC RESPIRATORY EQUIPMENT INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $82,829 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24725N0222_3600_36F79719D0024_3600 · retrieved 2026-09-26.